367 research outputs found
Suppressor T Cells in Human Diseases
Although central and peripheral tolerance are important for the regulation of human immune responses to self- and microbial antigens, an important role of suppressor CD4+ CD25+ T cells is suggested from the recent investigations of human autoimmune diseases and HIV. These new data provide increasing evidence that altered function of CD4+ CD25+ T cells may be an important factor in a wide range of human inflammatory and infectious diseases
TIMs: central regulators of immune responses
Exhaustion of T cell responses during chronic viral infections has been observed in both mouse and man and has been attributed to up-regulation of PD-1 on the surface of exhausted T cells. In patients with chronic human HIV infection, T cell exhaustion leads to opportunistic infections associated with AIDS. However, not all the exhausted T cells express PD-1, suggesting that other molecules may be involved in the phenotype. A new study now demonstrates a central role for T cell immunoglobulin and mucin domainâcontaining protein-3 (TIM-3) in T cell exhaustion during chronic HIV infection and suggests that TIM-3 may be a novel therapeutic target in chronic viral diseases
Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells
July 15, 2010Although it has long been known that human CD4+ T cells can express functional class II MHC molecules, the role of lysosomal proteases in the T cell class II MHC processing and presentation pathway is unknown. Using CD4+ T cell clones that constitutively express class II MHC, we determined that cathepsin S is necessary for invariant chain proteolysis in T cells. CD4+HLA-DR+ T cells down-regulated cathepsin S expression and activity 18 h after activation, thereby ceasing nascent class II MHC product formation. This blockade resulted in the loss of the invariant chain fragment CLIP from the cell surface, suggesting thatâlike professional APCâCD4+ HLA-DR+ cells modulate self-Ag presentation as a consequence of activation. Furthermore, cathepsin S expression and activity, and concordantly cell surface CLIP expression, was reduced in HLA-DR+ CD4+ T cells as compared with B cells both in vitro and ex vivo
HTLV-I-Infected T Cells Evade the Antiproliferative Action of IFN-β
AbstractHuman T-cell lymphotropic virus type I (HTLV-I)-infected T-cell clones enter the S-phase of the cell cycle in the absence of exogenous IL-2. The pathway by which HTLV-I activates the host T cell may circumvent normal immunoregulatory mechanisms and thus be important for the pathogenesis of HTLV-I-induced diseases. The early control of viral infections is in part mediated by interferons (IFNs), which possess both antiviral and antiproliferative functions. In order to investigate the antiproliferative effect of IFN-β on HTLV-I-induced T-cell activation, we generated T-cell clones from patients with HTLV-I-associated myelopathy/tropical spastic paraparesis by single-cell cloning under limiting dilution conditions. Here we demonstrate that HTLV-I-induced T-cell proliferation is resistant to the antiproliferative action of IFN-β. Moreover, HTLV-I-infected T-cell clones continue to constitutively secrete IFN-γ in the presence of high doses of IFN-β. HTLV-I-infected T cells express normal levels of IFNAR1 and are able to respond to IFN-β by phosphorylation of STAT1 on Tyr701, although they display a relative increase in phosphorylation of the transcriptionally inactive STAT1β when compared with STAT1ι. Thus, HTLV-I promotes cell cycle progression in G1by a mechanism that overcomes inhibitory signals, thereby circumventing an innate immune defense mechanism
Recommended from our members
Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers
Currently, there is no single test for multiple sclerosis (MS). Diagnosis is confirmed through clinical evaluation, abnormalities revealed by magnetic resonance imaging (MRI), and analysis of cerebrospinal fluid (CSF) chemistry. The early and accurate diagnosis of the disease, monitoring of progression, and gauging of therapeutic intervention are important but elusive elements of patient care. Moreover, a deeper understanding of the disease pathology is needed, including discovery of accurate biomarkers for MS. Herein we review putative biomarkers of MS relating to neurodegeneration and contributions to neuropathology, with particular focus on autoimmunity. In addition, novel assessments of biomarkers not driven by hypotheses are discussed, featuring our application of advanced proteomics and metabolomics for comprehensive phenotyping of CSF and blood. This strategy allows comparison of component expression levels in CSF and serum between MS and control groups. Examination of these preliminary data suggests that several CSF proteins in MS are differentially expressed, and thus, represent putative biomarkers deserving of further evaluation
Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric Data
In systems biomedicine, an experimenter encounters different potential
sources of variation in data such as individual samples, multiple experimental
conditions, and multi-variable network-level responses. In multiparametric
cytometry, which is often used for analyzing patient samples, such issues are
critical. While computational methods can identify cell populations in
individual samples, without the ability to automatically match them across
samples, it is difficult to compare and characterize the populations in typical
experiments, such as those responding to various stimulations or distinctive of
particular patients or time-points, especially when there are many samples.
Joint Clustering and Matching (JCM) is a multi-level framework for simultaneous
modeling and registration of populations across a cohort. JCM models every
population with a robust multivariate probability distribution. Simultaneously,
JCM fits a random-effects model to construct an overall batch template -- used
for registering populations across samples, and classifying new samples. By
tackling systems-level variation, JCM supports practical biomedical
applications involving large cohorts
Dysregulated T cell expression of TIM3 in multiple sclerosis
T cell immunoglobulin- and mucin domainâcontaining molecule (TIM)3 is a T helper cell (Th)1âassociated cell surface molecule that regulates Th1 responses and promotes tolerance in mice, but its expression and function in human T cells is unknown. We generated 104 T cell clones from the cerebrospinal fluid (CSF) of six patients with multiple sclerosis (MS) (n = 72) and four control subjects (n = 32) and assessed their cytokine profiles and expression levels of TIM3 and related molecules. MS CSF clones secreted higher amounts of interferon (IFN)-Îł than did those from control subjects, but paradoxically expressed lower levels of TIM3 and T-bet. Interleukin 12âmediated polarization of CSF clones induced substantially higher amounts of IFN-Îł secretion but lower levels of TIM3 in MS clones relative to control clones, demonstrating that TIM3 expression is dysregulated in MS CSF clones. Reduced levels of TIM3 on MS CSF clones correlated with resistance to tolerance induced by costimulatory blockade. Finally, reduction of TIM3 on ex vivo CD4+ T cells using small interfering (si)RNA enhanced proliferation and IFN-Îł secretion, directly demonstrating that TIM3 expression on human T cells regulates proliferation and IFN-Îł secretion. Failure to up-regulate T cell expression of TIM3 in inflammatory sites may represent a novel, intrinsic defect that contributes to the pathogenesis of MS and other human autoimmune diseases
Role of âWestern Dietâ in Inflammatory Autoimmune Diseases
Developed societies, although having successfully reduced the burden of infectious disease, constitute an environment where metabolic, cardiovascular, and autoimmune diseases thrive. Living in westernized countries has not fundamentally changed the genetic basis on which these diseases emerge, but has strong impact on lifestyle and pathogen exposure. In particular, nutritional patterns collectively termed the âWestern dietâ, including high-fat and cholesterol, high-protein, high-sugar, and excess salt intake, as well as frequent consumption of processed and âfast foodsâ, promote obesity, metabolic syndrome, and cardiovascular disease. These factors have also gained high interest as possible promoters of autoimmune diseases. Underlying metabolic and immunologic mechanisms are currently being intensively explored. This review discusses the current knowledge relative to the association of âWestern dietâ with autoimmunity, and highlights the role of T cells as central players linking dietary influences to autoimmune pathology.National Institutes of Health (U.S.) (NIH grant P30-ES002109
- âŚ